肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

中国急性早幼粒细胞白血病诊疗指南（2018年版）

2018-05-24 中华医学会血液学分会

急性早幼粒细胞性白血病

急性早幼粒细胞白血病(APL)是一种特殊类型的急性髓系白血病(AML),绝大多数患者具有特异性染色体易位t(15;17) (q22;q12),形成PML-RARα融合基因,其蛋白产物导致细胞分化阻滞和凋亡不足,是APL发生的主要分子机制.APL易见于中青年人,平均发病年龄为44岁,APL占同期AML的10％～15％,发病率约0.23/10万.APL临床表现凶险,起病及诱导治疗过程中容易发生出血

中文标题：

中国急性早幼粒细胞白血病诊疗指南（2018年版）

英文标题：

Chinese guidelines for diagnosis and treatment of acute promyelocytic leukemia (2018)

发布机构：

中华医学会血液学分会

发布日期：

2018-05-24

简要介绍：

急性早幼粒细胞白血病(APL)是一种特殊类型的急性髓系白血病(AML),绝大多数患者具有特异性染色体易位t(15;17) (q22;q12),形成PML-RARα融合基因,其蛋白产物导致细胞分化阻滞和凋亡不足,是APL发生的主要分子机制.APL易见于中青年人,平均发病年龄为44岁,APL占同期AML的10％～15％,发病率约0.23/10万.APL临床表现凶险,起病及诱导治疗过程中容易发生出血和栓塞而引起死亡.近三十年来,由于全反式维甲酸(ATRA)及砷剂的规范化临床应用,APL已成为基本不用进行造血干细胞移植即可治愈的白血病.

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1056024, encodeId=0f8b105602483, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56545167768, createdName=146cdb0fm09暂无昵称, createdTime=Wed Sep 29 12:26:14 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007073, encodeId=3ccf100e07326, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:35 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007072, encodeId=d95e100e07270, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:19 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000005, encodeId=958e1000005cf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:56:15 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974380, encodeId=65ac9e4380a5, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Thu Jun 17 14:04:05 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-09-29 146cdb0fm09暂无昵称

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1056024, encodeId=0f8b105602483, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56545167768, createdName=146cdb0fm09暂无昵称, createdTime=Wed Sep 29 12:26:14 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007073, encodeId=3ccf100e07326, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:35 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007072, encodeId=d95e100e07270, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:19 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000005, encodeId=958e1000005cf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:56:15 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974380, encodeId=65ac9e4380a5, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Thu Jun 17 14:04:05 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-08-11 ms3000002031095801

    非常感谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1056024, encodeId=0f8b105602483, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56545167768, createdName=146cdb0fm09暂无昵称, createdTime=Wed Sep 29 12:26:14 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007073, encodeId=3ccf100e07326, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:35 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007072, encodeId=d95e100e07270, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:19 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000005, encodeId=958e1000005cf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:56:15 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974380, encodeId=65ac9e4380a5, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Thu Jun 17 14:04:05 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-08-11 ms3000002031095801

    非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1056024, encodeId=0f8b105602483, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56545167768, createdName=146cdb0fm09暂无昵称, createdTime=Wed Sep 29 12:26:14 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007073, encodeId=3ccf100e07326, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:35 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007072, encodeId=d95e100e07270, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:19 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000005, encodeId=958e1000005cf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:56:15 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974380, encodeId=65ac9e4380a5, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Thu Jun 17 14:04:05 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-07-16 ms9000000012500818

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1056024, encodeId=0f8b105602483, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56545167768, createdName=146cdb0fm09暂无昵称, createdTime=Wed Sep 29 12:26:14 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007073, encodeId=3ccf100e07326, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:35 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007072, encodeId=d95e100e07270, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de95570739, createdName=ms3000002031095801, createdTime=Wed Aug 11 21:25:19 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000005, encodeId=958e1000005cf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:56:15 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974380, encodeId=65ac9e4380a5, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Thu Jun 17 14:04:05 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-06-17 妙医生

    非常好！

    0

以上为热门评论，梅斯医学App还有更多内容